Supha Pharmachem Limited (BOM:539561)
India · Delayed Price · Currency is INR 0.4300
-0.0200 (-4.44%)
At close: Mar 6, 2026
Supha Pharmachem Market Cap
Supha Pharmachem has a market cap or net worth of 173.38 million as of March 6, 2026. Its market cap has decreased by -88.44% in one year.
Market Cap
173.38M
Enterprise Value
11.04B
Revenue
5.27B
Ranking
n/a
PE Ratio
2.30
Stock Price
0.43
Market Cap Chart
Since May 25, 2018, Supha Pharmachem's market cap has increased from 45.36M to 173.38M, an increase of 282.23%. That is a compound annual growth rate of 18.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 173.38M | -42.67% |
| Dec 31, 2025 | 302.40M | -85.35% |
| Dec 31, 2024 | 2.06B | -79.58% |
| Dec 29, 2023 | 10.11B | 1,895.62% |
| Dec 30, 2022 | 506.52M | 1.22% |
| Dec 31, 2021 | 500.40M | 194.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Accretion Nutraveda | 1.31B |
| Krebs Biochemicals & Industries | 1.20B |
| Tyche Industries | 1.10B |
| Resonance Specialties | 1.07B |
| Bacil Pharma | 696.12M |
| Vasundhara Rasayans | 381.38M |
| Crestchem | 267.81M |
| Ishita Drugs and Industries | 202.14M |